Evidence map›Paper›PMID 36554180›Full record

ArticleEntropy (Basel, Switzerland)2022

Efficient System for Delimitation of Benign and Malignant Breast Masses.

Dante Mújica-Vargas, Manuel Matuz-Cruz, Christian García-Aquino, Celia Ramos-Palencia

Abstract read
In one paragraph

Article in Entropy (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dante Mújica-VargasDepartamento de Ciencias Computacionales, Tecnológico Nacional de México, Centro Nacional de Investigación y Desarrollo Tecnológico, Cuernavaca 62490, Morelos, Mexico.ORCID 0000-0001-8665-4096
Manuel Matuz-CruzTecnológico Nacional de México, Instituto Tecnológico de Tapachula, Tapachula 30700, Chiapas, Mexico.ORCID 0000-0002-9511-7572
Christian García-AquinoDepartamento de Ciencias Computacionales, Tecnológico Nacional de México, Centro Nacional de Investigación y Desarrollo Tecnológico, Cuernavaca 62490, Morelos, Mexico.
Celia Ramos-PalenciaDepartamento de Ciencias Computacionales, Tecnológico Nacional de México, Centro Nacional de Investigación y Desarrollo Tecnológico, Cuernavaca 62490, Morelos, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, a high-performing scheme is introduced to delimit benign and malignant masses in breast ultrasound images. The proposal is built upon by the Nonlocal Means filter for image quality improvement, an Intuitionistic Fuzzy C-Means local clustering algorithm for superpixel generation with high adherence to the edges, and the DBSCAN algorithm for the global clustering of those superpixels in order to delimit masses' regions. The empirical study was performed using two datasets, both with benign and malignant breast tumors. The quantitative results with respect to the BUSI dataset were JSC≥0.907, DM≥0.913, HD≥7.025, and MCR≤6.431 for benign masses and JSC≥0.897, DM≥0.900, HD≥8.666, and MCR≤8.016 for malignant ones, while the MID dataset resulted in JSC≥0.890, DM≥0.905, HD≥8.370, and MCR≤7.241 along with JSC≥0.881, DM≥0.898, HD≥8.865, and MCR≤7.808 for benign and malignant masses, respectively. These numerical results revealed that our proposal outperformed all the evaluated comparative state-of-the-art methods in mass delimitation. This is confirmed by the visual results since the segmented regions had a better edge delimitation.

Indexed as

benign and malignant breast tumorsbreast masses delimitationDBSCANintuitionistic fuzzy clusteringnonlocal meansultrasound image

Identifiers

PMID36554180
PMCPMC9777637

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.